Cargando…

The Highly Expressed FAM83F Protein in Papillary Thyroid Cancer Exerts a Pro-Oncogenic Role in Thyroid Follicular Cells

Thyroid cancer is the most common endocrine cancer with predominant prevalence of papillary thyroid cancer (PTC) histotype. MAPK signaling genetic alterations are frequent in PTC, affecting more than 80% of cases. These alterations constitutively activate MAPK signaling cross-regulating different pr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fuziwara, Cesar Seigi, Saito, Kelly Cristina, Leoni, Suzana Garcia, Waitzberg, Ângela Flávia Logullo, Kimura, Edna Teruko
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6407429/ https://www.ncbi.nlm.nih.gov/pubmed/30881348 http://dx.doi.org/10.3389/fendo.2019.00134

Ejemplares similares

MicroRNA Deregulation in Anaplastic Thyroid Cancer Biology
por: Fuziwara, Cesar Seigi, et al.
Publicado: (2014)

How does microRNA modulate Wnt/β-catenin signaling in thyroid oncogenesis?
por: Fuziwara, Cesar Seigi, et al.
Publicado: (2020)

Gene Editing with CRISPR/Cas Methodology and Thyroid Cancer: Where Are We?
por: Fuziwara, Cesar Seigi, et al.
Publicado: (2022)

MiRNA-146b-5p upregulates migration and invasion of different Papillary Thyroid Carcinoma cells
por: Lima, Cilene Rebouças, et al.
Publicado: (2016)

Interplay of TGFβ signaling and microRNA in thyroid cell loss of differentiation and cancer progression
por: Fuziwara, Cesar Seigi, et al.
Publicado: (2019)

Genetic Mutations and Variants in the Susceptibility of Familial Non-Medullary Thyroid Cancer
por: Miasaki, Fabíola Yukiko, et al.
Publicado: (2020)

Insights into Regulation of the miR-17-92 Cluster of miRNAs in Cancer
por: Fuziwara, Cesar Seigi, et al.
Publicado: (2015)

Modulation of EZH2 Activity Induces an Antitumoral Effect and Cell Redifferentiation in Anaplastic Thyroid Cancer
por: de Mello, Diego Claro, et al.
Publicado: (2023)

Targeting the Highly Expressed microRNA miR-146b with CRISPR/Cas9n Gene Editing System in Thyroid Cancer
por: de Santa-Inez, Daniel Casartelli, et al.
Publicado: (2021)

FAM83A and FAM83A-AS1 both play oncogenic roles in lung adenocarcinoma
por: Wang, Gaoming, et al.
Publicado: (2021)

FAM83B is involved in thyroid cancer cell differentiation and migration
por: Cirello, Valentina, et al.
Publicado: (2022)

Identification of Long Noncoding RNAs Deregulated in Papillary Thyroid Cancer and Correlated with BRAF(V600E) Mutation by Bioinformatics Integrative Analysis
por: Goedert, Lucas, et al.
Publicado: (2017)

Papillary and follicular thyroid carcinomas show a different pattern of ras oncogene mutation.
por: Wright, P. A., et al.
Publicado: (1989)

hnRNP A1 and hnRNP C associate with miR‐17 and miR‐18 in thyroid cancer cells
por: dos Santos, Maria Gabriela Pereira, et al.
Publicado: (2022)

Immunohistochemistry Helps to Distinguish Noninvasive Follicular Thyroid Neoplasm with Papillary-like Nuclear Features/Noninvasive Encapsulated Follicular Variant of Papillary Thyroid Carcinoma with Other Follicular Thyroid Lesions
por: Chuang, Hao-Wen, et al.
Publicado: (2021)

Proteomic profiling of follicular and papillary thyroid tumors
por: Sofiadis, Anastasios, et al.
Publicado: (2012)

Synchronous primary hyperparathyroidism, follicular thyroid carcinoma, and papillary thyroid carcinoma
por: Dai, Dong-Jun, et al.
Publicado: (2019)

FAM83A exerts tumor-suppressive roles in cervical cancer by regulating integrins
por: Xu, Junfen, et al.
Publicado: (2020)

Comparison of microarray expression profiles between follicular variant of papillary thyroid carcinomas and follicular adenomas of the thyroid
por: Schulten, Hans-Juergen, et al.
Publicado: (2015)

Down-regulation of 14q32-encoded miRNAs and tumor suppressor role for miR-654-3p in papillary thyroid cancer
por: Geraldo, Murilo Vieira, et al.
Publicado: (2016)

Hyperactivation of EGFR and downstream effector phospholipase D1 by oncogenic FAM83B
por: Cipriano, Rocky, et al.
Publicado: (2013)

FAM83 proteins: Fostering new interactions to drive oncogenic signaling and therapeutic resistance
por: Bartel, Courtney A., et al.
Publicado: (2016)

FAM83A and FAM83B as Prognostic Biomarkers and Potential New Therapeutic Targets in NSCLC
por: Richtmann, Sarah, et al.
Publicado: (2019)

Parental cancer and risk of papillary and follicular thyroid carcinoma.
por: Galanti, M. R., et al.
Publicado: (1997)

Mouse Models of Follicular and Papillary Thyroid Cancer Progression
por: Russo, Marika A., et al.
Publicado: (2012)

Follicular variant papillary thyroid carcinoma with a twist
por: Nwaeze, Obinna, et al.
Publicado: (2015)

Follicular Variant of Papillary Thyroid Carcinoma: Hybrid or Mixture?
por: Daniels, Gilbert H.
Publicado: (2016)

Rare behavior of follicular variant of papillary thyroid cancer
por: Helmi, Hadeel, et al.
Publicado: (2017)

Surgical management for follicular variant of papillary thyroid carcinoma
por: Tang, Jianing, et al.
Publicado: (2017)

FAM172A promotes follicular thyroid carcinogenesis and may be a marker of FTC
por: Xu, Pei-Pei, et al.
Publicado: (2020)

FAM83 family oncogenes are broadly involved in human cancers: an integrative multi‐omics approach
por: Snijders, Antoine M., et al.
Publicado: (2017)

FAM83H‐AS1 is a noncoding oncogenic driver and therapeutic target of lung adenocarcinoma
por: Wang, Siwei, et al.
Publicado: (2021)

Rethinking the Role of Oncogenes in Papillary Thyroid Cancer Initiation
por: Vitale, Mario
Publicado: (2012)

CUX2 functions as an oncogene in papillary thyroid cancer
por: Sun, Yihan, et al.
Publicado: (2018)

Concurrent Papillary and Follicular Thyroid Cancer Presenting as Shoulder Pain
por: Santiago Carrion, Ada Marie, et al.
Publicado: (2021)

The Role of Claudin-1 Expression in Follicular and Papillary Thyroid Neoplasm
por: Miskad, Upik Anderiani, et al.
Publicado: (2022)

Impact of Reclassification on Thyroid Nodules with Architectural Atypia: From Non-Invasive Encapsulated Follicular Variant Papillary Thyroid Carcinomas to Non-Invasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features
por: Jeon, Min Ji, et al.
Publicado: (2016)

A case of concurrent occurrence of carcinoma showing thymus-like differentiation and follicular variant of papillary thyroid cancer in the same thyroid
por: Kimura, Takahito, et al.
Publicado: (2022)

Evolutionary analysis of FAM83H in vertebrates
por: Huang, Wushuang, et al.
Publicado: (2017)

HER2-positive breast cancer cells expressing elevated FAM83A are sensitive to FAM83A loss
por: Bartel, Courtney A., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_ovrsab92hdlh7usc2u3tb65ef5